It seems that biotechnology is finding investors in our country. A few weeks ago we told you that Inveready had invested in Cuantum and Ab-biotics, this week we learned that Oncostellae, which received a €1M round is looking for funding, and Caixa Capital Risk has led a €2.2M round in Inbiomotion.
M&A advisors with expertise in the technology sector
News
Latest Sectoral Reports |
There is not content matching the selected criteria
Last Entries
Divestment of Avet Ventures in the Catalan company Nuroa
Investors are benefiting from acquisitions in the classifieds technology market. Last year we saw Cabiedes and Partners successfully sell Trovit to Japan's Next CO. We also witnessed how the sale of Milanuncios was one of the most successful divestments in the history of Spain for an entrepreneur. Now we have learned that Mitula Group has bought the Catalan company Nuroa.
Roca buys Turkish company NSK
After several years in which the Roca Group had to carry out a policy of restructuring and adjustment, in 2014 it returned with force by buying 6 companies to grow internationally and now we have learned that it has bought the Turkish company NSK, a Turkish faucet company whose main client is Ikea.
Iberoeka Argentina and Iberoeka Uruguay open calls for proposals
The Iberoeka calls aim to promote the technological internationalisation of Spanish companies in Latin America through the development of collaborative R&D projects of a business nature. A few weeks ago, we announced the Iberoeka...
What are the keys to getting your startup funded? Odilo and Immfly as an example
There is a significant amount of capital seeking to be invested in innovation projects, but investors are looking for successful operations and are guided by criteria such as scalability, strong technological component and internationalisation capacity. Odilo and Immfly, which received €1.3M and €2.4M this February, are two examples.
New venture capital funds for SMEs: Meridia capital and Closa Gordon Investment
Meridia Capital and Closa Gordon, two companies familiar with investment, have decided to move into private equity and are setting up funds to invest in Spanish SMEs.
Spain leading country in participation in SME instrument phase 1 (November 2015)
From the last SME instrument phase 1 call, with cut-off date November 2015, 185 companies have been selected out of the 2057 proposals submitted. The projects come from 22 different countries, Spain with a participation of 22%, which means 39 projects, is the country where more projects have been selected. These companies will receive €50,000 in funding.
Carlyle buys Digitex: Venture capitalists are interested in the outsourcing industry
In the last year we have seen how large funds have realised the opportunity presented by the European outsourcing market and have decided to invest in the sector. In Spain in particular, yesterday we learned about the purchase of Digitex by Carlyle, but already last September the French fund PAI Partners bought Konecta.
GFK buys Spanish online panel provider Netquest
The German Gfk Group, one of the international references in the field of market research, and author of dozens of studies of great relevance every year, has bought the Spanish company Netquest, which focuses its activity on digital panels.
Nuclio, the venture builder founded by Carlos Blanco, is born.
Carlos Blanco starts a new stage, puts an end to Grupo Itnet and founds Nuclio Venture Builder, a company builder of digital and disruptive businesses from which he will promote all his projects from now on.
Regional R&D funding programmes
Andalucía ya ha abierto las ayudas «incentivos a pymes para el desarrollo industrial y la creación de empleo en andalucía» aprovechando que ya han salido las primeras, hemos querido hacer un repaso de las ayudas regionales a la innovación que se prevé que saldrán este año.
Inveready bets on biotechnology, invests in Cuantum and AB-biotics in less than a month
Inveready has started the year with a strong commitment to biotechnology. A few weeks ago we announced that it had invested in Oncostellae, and recently we have learned that it has invested in two more companies, in Ab-BIOTICS through its debt fund and in Cuantum through its Inveready Biotech II fund.